Listed on the Euronext Paris market and 59% owned, is based in Marcy l’Etoile (France).
World leader of in vitro diagnostics and industrial microbiological controls,
bioMérieux employs 6,400 people. With a global presence in 150 countries, the group has
a network of 39 subsidiaries and generates revenues amounting to 1,111 billion Euros.
Based in Strasburg (France), this biotech company is 55% controlled and is listed
on the Paris stock exchange Euronext. With 250 people, it develops immunotherapy products
for the treatment of cancer and infectious diseases.
Privately-owned company, 89% controlled, based in Chicago (United States).
Encompassing a network of nearly 50 laboratories dedicated to improving food safety and nutrition,
with 3,000 employees, Silliker operates in 16 countries today.
(Advanced BioScience Laboratories), is a privately-owned company 100% controlled,
based in Washington D.C. (US). ABL employs 100 people specialized in virological research.